Certara (NASDAQ:CERT) Now Covered by Analysts at JMP Securities

Equities researchers at JMP Securities began coverage on shares of Certara (NASDAQ:CERTGet Free Report) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The brokerage set a “market perform” rating on the stock.

CERT has been the topic of several other reports. SVB Leerink initiated coverage on shares of Certara in a research note on Monday, February 26th. They issued a “market perform” rating and a $19.00 price target on the stock. UBS Group raised their target price on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research note on Friday, March 1st. Jefferies Financial Group upped their price target on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research report on Friday, March 1st. Leerink Partnrs reiterated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. Finally, Barclays upped their target price on Certara from $16.00 to $18.00 and gave the company an “equal weight” rating in a report on Thursday, January 25th. Eight analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $19.64.

Get Our Latest Stock Report on CERT

Certara Stock Down 0.4 %

CERT opened at $16.88 on Thursday. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.28. Certara has a twelve month low of $11.81 and a twelve month high of $24.96. The company has a market cap of $2.70 billion, a PE ratio of -48.23, a price-to-earnings-growth ratio of 1.74 and a beta of 1.63. The company has a 50-day moving average price of $17.57 and a 200 day moving average price of $15.89.

Certara (NASDAQ:CERTGet Free Report) last released its earnings results on Thursday, February 29th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The firm had revenue of $88.01 million during the quarter, compared to analysts’ expectations of $86.80 million. Sell-side analysts expect that Certara will post 0.29 earnings per share for the current fiscal year.

Insider Activity at Certara

In other Certara news, SVP Richard M. Traynor sold 6,000 shares of Certara stock in a transaction on Monday, February 12th. The shares were sold at an average price of $18.00, for a total value of $108,000.00. Following the transaction, the senior vice president now directly owns 165,368 shares in the company, valued at $2,976,624. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, SVP Richard M. Traynor sold 6,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $18.00, for a total transaction of $108,000.00. Following the transaction, the senior vice president now owns 165,368 shares of the company’s stock, valued at $2,976,624. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the transaction, the senior vice president now owns 173,524 shares in the company, valued at $3,123,432. The disclosure for this sale can be found here. 2.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Tower Research Capital LLC TRC increased its position in Certara by 584.8% in the second quarter. Tower Research Capital LLC TRC now owns 1,356 shares of the company’s stock worth $25,000 after buying an additional 1,158 shares during the period. Pineridge Advisors LLC acquired a new position in Certara during the fourth quarter valued at $28,000. State of Wyoming raised its position in Certara by 103.1% during the second quarter. State of Wyoming now owns 2,027 shares of the company’s stock valued at $37,000 after buying an additional 1,029 shares during the period. Covestor Ltd boosted its position in Certara by 14,940.0% during the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after acquiring an additional 3,735 shares during the period. Finally, Advisors Asset Management Inc. boosted its position in Certara by 42.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 4,710 shares of the company’s stock worth $68,000 after acquiring an additional 1,414 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Certara Company Profile

(Get Free Report)

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Further Reading

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.